GlaxoSmithKline (GSK) can trace its roots back to a small apothecary in 18th Century London. Through multiple corporate mergers, GSK found its current form in 2001. It is well-known for its asthma inhalers like Advair and Breo. But it is infamous for a bribing scandal in China. The company has also battled lawsuits that blame its products for injuries.
GlaxoSmithKline is a Big Pharma corporation. It sits at No. 194 on Forbes’ list of the 2,000 largest companies in the world.
The British pharmaceutical company is well-known for its respiratory products like Advair and Ventolin.
But GSK has faced allegations of unethical and unsafe business practices. Some of its former employees were criminally prosecuted on two different continents.
Some of GSK’s popular pharmaceuticals have harmed patients. Injuries led to product liability lawsuits.
GlaxoSmithKline is a global health care company with headquarters in Brentford, London.
Emma Walmsley is GSK’s CEO. She is the first woman to be chief executive of a major pharmaceutical corporation.
Total revenues for GSK reached $30.2 billion pounds in 2017. This equates to $40.4 billion in U.S. currency.
GSK employs nearly 100,000 people in over 150 countries. Its U.S. headquarters are in Philadelphia. GSK has a separate research facility in North Carolina.
GlaxoSmithKline started in 1715 as Plough Court pharmacy, a small apothecary shop in London. GSK evolved through a series of mergers over two centuries.
GSK focuses on vaccines, pharmaceutical drugs and consumer health care products. It sold 798 million doses of vaccines in 2017.
GSK is the maker of the industry’s broadest range of inhaled respiratory products. These include Advair, Ventolin and Breo Ellipta. The products are the company’s biggest moneymaker.
The company has also partnered with Pfizer and Shionogi to form a global HIV business, ViiV Healthcare. The business accounts for more than 20 percent of GlaxoSmithKline’s pharmaceutical sales.
GlaxoSmithKline has faced a number of product liability lawsuits. Patients filing lawsuits accuse the company of manufacturing dangerous or defective products.
Suicidal thoughts and birth defects
Strokes, heart attacks and heart failure
GSK faced 445 Zofran lawsuits in May 2018.
In 2012, GlaxoSmithKline pleaded guilty to federal criminal offenses. The company’s crimes included misbranding of its antidepressants Paxil and Wellbutrin. GSK also failed to report safety data to the FDA about its diabetes drug Avandia.
GSK admitted to illegally promoting Paxil for treatment of depression in children.
The company reached a civil settlement with the U.S. federal government in which it agreed to pay a fine of $3 billion.
The plea represented the largest health care fraud settlement in U.S. history. It resolved allegations of pricing fraud.
GSK reached a related civil settlement with the U.S. Justice Department. It resolved allegations of improper marketing of Advair and Zofran.
GlaxoSmithKline recalled some of it products for defects, possible tampering and reduced effectiveness. Products affected include consumer weight loss products, vaccines and albuterol inhalers.
|2018||Ventolin and Seretide||200,000||Possible damaged foil strip containing medication inside the device resulting in reduced number of doses delivered by the inhaler|
|2017||Ventolin||600,000||Leak in the propellant that delivers the medicine resulting in a smaller dose of medication than indicated|
|2017||Menveo Meningococcal vaccine||Lot M16095 only (5 doses – 10 vials – per package)||Precautionary; the batch was subject to mechanical intervention during sanitary filling operations not supported by validation data|
|2015||Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes (PFS) flu vaccine||All remaining 2014-2015 doses||Potential for reduced effectiveness due to a decrease in vaccine strength prior to its expiration date found through routine testing|
|2015||Ventolin HFA||More than 128,000||Defective delivery system resulting in less than 200 doses|
|2014||Alli weight loss products||From all U.S. and Puerto Rico retailers||Some of the packages were tampered with and may contain product that is not alli|
A Chinese court ordered GlaxoSmithKline to pay $492 million in 2014. The fine resolved charges of bribing doctors in China to use GSK products. It was the biggest penalty ever imposed by a Chinese court.
The court sentenced Briton Mark Reilly to four years in prison. He was the company’s British executive for China. Four other Chinese employees received the same punishment.
But the employees may never serve prison time. The court postponed the sentences. Reilly was deported.
In February 2018, GSK was still answering to fraud investigators in its home country.
Please seek the advice of a medical professional before making health care decisions.
Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.
Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.(888) 645-1617